Analysts have raised their price target for Cameco to $146.44 from $124.81. They cite accelerating revenue growth and improving profit margins as key drivers behind the upward revision.
Analyst Commentary
Analysts covering Cameco continue to express strong conviction in the company's long-term trajectory, with sentiment generally positive but also highlighting areas to monitor.
Bullish Takeaways- Bullish analysts point to accelerating revenue growth as a significant driver of Cameco's higher valuation. This reflects confidence in both near-term results and longer-term expansion.
- Improving profit margins are noted as evidence of effective operational execution and rising efficiency across the company's business lines.
- The successful completion of major asset sales, along with favorable market dynamics, is seen as setting the stage for increased shareholder value and potential future capital allocation opportunities.
- Several analysts raise their forecasts for future earnings, citing Cameco's ability to capture market share as demand in its sector strengthens.
- Bearish analysts continue to caution about high leverage levels, which may pose risks if profitability or cash flow do not consistently meet expectations.
- Some express concerns that local and global market volatility, particularly in commodity pricing, could temper anticipated growth rates in the near term.
- There is also some hesitation regarding the sustainability of recent margin improvements, with competitive pressures and potential increases in operating costs being noted.
What's in the News
- Cameco and Brookfield Asset Management have entered into a strategic partnership with the US Department of Commerce to drive deployment of Westinghouse nuclear reactor technologies. The investment aims to support new reactors across the US. (Key Developments)
- Cameco provided consolidated guidance for 2025, projecting revenue between $3.3 billion and $3.55 billion and uranium production of up to 20 million pounds. (Key Developments)
- The company declared an annual dividend of CAD 0.24 per common share, to be paid in December 2025. (Key Developments)
- Recent production results show uranium output rose slightly to 4.4 million pounds in Q3 2025. Total production for the first nine months declined from the previous year, while fuel services production increased. (Key Developments)
- Cameco and Orano Canada signed a 15-year, $500 million agreement with Rise Air, enhancing workforce transportation for northern Saskatchewan operations. (Key Developments)
Valuation Changes
- Consensus Analyst Price Target has increased from CA$124.81 to CA$146.44, reflecting a notable upward revision.
- Discount Rate has risen slightly from 5.97% to 6.12%.
- Revenue Growth Expectations have climbed from 4.30% to 5.57%.
- Net Profit Margin is projected to improve from 35.37% to 36.12%.
- Future P/E Ratio has risen from 45.09x to 51.83x. This indicates higher valuation multiples assigned to Cameco's future earnings.
Have other thoughts on Cameco?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.